Literature DB >> 9808339

Genetics of psoriasis.

T Henseler1.   

Abstract

Non-pustular psoriasis consists of two disease subtypes, type I and type II, which demonstrate distinct characteristics. Firstly the disease presents in different decades of life, in type I before the age of 40 years and later in type II. Secondly, contrasting frequencies of HLA alleles are found: type I patients express predominantly HLA-Cw6, -B57, and -DR7, whereas in type II patients HLA-Cw2 is overrepresented. Finally, familial inheritance is found in type I but not in type II psoriasis. The study of concomitant diseases in psoriasis contributes to deciphering the distinct patterns of the disease. Defence against invading microorganisms seems better developed in psoriatics than in controls. This evolutionary benefit may have caused the overall high incidence of psoriasis of 2%. Psoriasis is a multifactorial and heterogenetically inherited disease. The heterogeneity is evident by the diversity of genetically linked markers. The multifactorial component results from the observation of external trigger mechanisms, such as the Koebner phenomenon, stress and the intake of certain drugs. Twin studies have shown that environmental factors contribute to the onset of the disease. In type I psoriasis, special extended haplotypes such as EH57.1 (HLA-Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303) and EH65.1 (HLA-Cw8-B65-DRB1*0102-DQB1*0501) have been found to be increased. The application of microsatellite techniques has identified distinct positions on several chromosomes at which putative psoriasis genes may be located. Disease susceptibility genes are thought to be present on chromosomes 4q, 6p, 16q, 17q and 20p. Moreover, on chromosome 1q, genes regulating epidermal differentiation have been identified. Linkage to this area has been proposed. Furthermore, psoriasis gene loci on chromosomes 2, 8 and 20 have been suggested.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9808339     DOI: 10.1007/s004030050338

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  10 in total

1.  Reduced IFN-gamma responses associated with HLA-DR15 presentation of streptococcal cell wall proteins to dermal Th-1 cells in psoriasis.

Authors:  Barbara S Baker; Jean-Marc Ovigne; Vincent A Fischetti; Anne Powles; Lionel Fry
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

2.  HLA Antigens in Omani Psoriasis Vulgaris Patients.

Authors:  Fatma Al-Mamari; Ali Al-Shirawi; Dd Banodkar; Suliman Al-Hashmi; Faiza Al-Yahyaae; Mathew Varghese; Ja Raeburn
Journal:  Oman Med J       Date:  2009-01

3.  Protective HIV-specific CD8+ T cells evade Treg cell suppression.

Authors:  Shokrollah Elahi; Warren L Dinges; Nicholas Lejarcegui; Kerry J Laing; Ann C Collier; David M Koelle; M Juliana McElrath; Helen Horton
Journal:  Nat Med       Date:  2011-07-17       Impact factor: 53.440

4.  A genetic risk score combining ten psoriasis risk loci improves disease prediction.

Authors:  Haoyan Chen; Annie Poon; Celestine Yeung; Cynthia Helms; Jennifer Pons; Anne M Bowcock; Pui-Yan Kwok; Wilson Liao
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

5.  Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis.

Authors:  P Y P C Ho; A Barton; J Worthington; D Plant; C E M Griffiths; H S Young; P Bradburn; W Thomson; A J Silman; I N Bruce
Journal:  Ann Rheum Dis       Date:  2007-08-29       Impact factor: 19.103

6.  Apolipoprotein E gene polymorphism and serum lipid profile in Saudi patients with psoriasis.

Authors:  Fahad Al Harthi; Ghaleb Bin Huraib; Abdulrahman Zouman; Misbahul Arfin; Mohammad Tariq; Abdulrahaman Al-Asmari
Journal:  Dis Markers       Date:  2014-03-23       Impact factor: 3.434

7.  An epidemiological study on trigger factors and quality of life in psoriatic patients.

Authors:  Alert Xhaja; Entela Shkodrani; Silvan Frangaj; Loreta Kuneshka; Ermira Vasili
Journal:  Mater Sociomed       Date:  2014-06-21

8.  Peroxisome Proliferator-Activated Receptor-γ Gene Polymorphism in Psoriasis and Its Relation to Obesity, Metabolic Syndrome, and Narrowband Ultraviolet B Response: A Case-Control Study in Egyptian Patients.

Authors:  Iman Seleit; Ola Ahmed Bakry; Eman Abd El Gayed; Mai Ghanem
Journal:  Indian J Dermatol       Date:  2019 May-Jun       Impact factor: 1.494

9.  Current concepts in the pathogenesis of psoriasis.

Authors:  Rajeev Patrick Das; Arun Kumar Jain; V Ramesh
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

10.  HLA-C, DRB1 and DQB1 alleles involved in genetic predisposition to psoriasis vulgaris in the Slovak population.

Authors:  Ivana Shawkatová; Juraj Javor; Zuzana Párnická; Peter Kozub; Mária Zilínková; Peter Frey; Stanislav Ferenčík; Milan Buc
Journal:  Folia Microbiol (Praha)       Date:  2012-11-27       Impact factor: 2.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.